BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19852802)

  • 1. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
    Nguyen TV; Sacci JB; de la Vega P; John CC; James AA; Kang AS
    Malar J; 2009 Oct; 8():235. PubMed ID: 19852802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.
    Egan JE; Hoffman SL; Haynes JD; Sadoff JC; Schneider I; Grau GE; Hollingdale MR; Ballou WR; Gordon DM
    Am J Trop Med Hyg; 1993 Aug; 49(2):166-73. PubMed ID: 8357078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen.
    Fidock DA; Pasquetto V; Gras H; Badell E; Eling W; Ballou WR; Belghiti J; Tartar A; Druilhe P
    Eur J Immunol; 1997 Oct; 27(10):2502-13. PubMed ID: 9368603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.
    Calle JM; Nardin EH; Clavijo P; Boudin C; Stüber D; Takacs B; Nussenzweig RS; Cochrane AH
    J Immunol; 1992 Oct; 149(8):2695-701. PubMed ID: 1401909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis.
    Felgner PL; Roestenberg M; Liang L; Hung C; Jain A; Pablo J; Nakajima-Sasaki R; Molina D; Teelen K; Hermsen CC; Sauerwein R
    Sci Rep; 2013 Dec; 3():3549. PubMed ID: 24351974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
    de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
    Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor.
    Chappel JA; Rogers WO; Hoffman SL; Kang AS
    Malar J; 2004 Jul; 3():28. PubMed ID: 15283866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Antigens Derived from
    Pratt-Riccio LR; De Souza Perce-Da-Silva D; Da Costa Lima-Junior J; Pratt Riccio EK; Ribeiro-Alves M; Santos F; Arruda M; Camus D; Druilhe P; Oliveira-Ferreira J; Daniel-Ribeiro CT; Banic DM
    Am J Trop Med Hyg; 2017 Nov; 97(5):1581-1592. PubMed ID: 29016339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex.
    Przysiecki C; Lucas B; Mitchell R; Carapau D; Wen Z; Xu H; Wang XM; Nahas D; Wu C; Hepler R; Ottinger E; Ter Meulen J; Kaslow D; Shiver J; Nardin E
    Front Cell Infect Microbiol; 2012; 2():146. PubMed ID: 23226683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.
    Herrington D; Davis J; Nardin E; Beier M; Cortese J; Eddy H; Losonsky G; Hollingdale M; Sztein M; Levine M
    Am J Trop Med Hyg; 1991 Nov; 45(5):539-47. PubMed ID: 1951863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites.
    Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES
    Malar J; 2019 May; 18(1):186. PubMed ID: 31142328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection.
    Peng K; Goh YS; Siau A; Franetich JF; Chia WN; Ong AS; Malleret B; Wu YY; Snounou G; Hermsen CC; Adams JH; Mazier D; Preiser PR; Sauerwein RW; Grüner AC; Rénia L
    Cell Microbiol; 2016 Dec; 18(12):1739-1750. PubMed ID: 27130708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.
    Sina BJ; do Rosario VE; Woollett G; Sakhuja K; Hollingdale MR
    Exp Parasitol; 1993 Sep; 77(2):129-35. PubMed ID: 8375482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.
    Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S
    Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes.
    Chappel JA; Hollingdale MR; Kang AS
    Hum Antibodies; 2004; 13(3):91-6. PubMed ID: 15598989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in the acquisition of naturally acquired antibodies to cell-traversal protein for ookinetes and sporozoites (CelTOS) and thrombospondin-related adhesion protein (TRAP) of Plasmodium falciparum in naturally infected patients from unstable malaria areas in Iran.
    Pirahmadi S; Zakeri S; Mehrizi AA; Karimi L; Djadid ND
    Acta Trop; 2019 Feb; 190():365-374. PubMed ID: 30543766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.
    Chatterjee S; Wery M; Sharma P; Chauhan VS
    Infect Immun; 1995 Nov; 63(11):4375-81. PubMed ID: 7591073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.